{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:42:32Z","timestamp":1785213752693,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003151","name":"Fonds de recherche du Qu\u00e9bec \u2013 Nature et technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019619","name":"International Diabetes Federation","doi-asserted-by":"publisher","award":["2021-2023"],"award-info":[{"award-number":["2021-2023"]}],"id":[{"id":"10.13039\/100019619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019619","name":"International Diabetes Federation","doi-asserted-by":"publisher","award":["T.0009.21"],"award-info":[{"award-number":["T.0009.21"]}],"id":[{"id":"10.13039\/100019619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015573","name":"Centre Eau Terre Environnement, Institut National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011068","name":"Fondation Saint Luc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FRQ-FNRS - PINT-BILAT-P 2018"],"award-info":[{"award-number":["FRQ-FNRS - PINT-BILAT-P 2018"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["ARC 18\/23-094"],"award-info":[{"award-number":["ARC 18\/23-094"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ebiom.2024.105264","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T03:22:20Z","timestamp":1723087340000},"page":"105264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-1787","authenticated-orcid":false,"given":"Anne-Catherine","family":"Pouleur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassiba","family":"Menghoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7255-5648","authenticated-orcid":false,"given":"Julien","family":"Cumps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-6576","authenticated-orcid":false,"given":"Alice","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Badii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibille","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Thompson","family":"Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gruson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Battault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louiza","family":"Mahrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pedneault-Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Furtos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rhainds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-8983","authenticated-orcid":false,"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-8440","authenticated-orcid":false,"given":"Christine Des","family":"Rosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Horman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1665-8267","authenticated-orcid":false,"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ebiom.2024.105264_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105264_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105264_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105264_bib4","first-page":"1110","article-title":"Transitioning from preclinical to clinical heart failure with preserved ejection fraction: a mechanistic approach","volume":"9","author":"Bayes-Genis","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105264_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105264_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cca.2015.12.007","article-title":"Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: a cross-sectional study","volume":"453","author":"Maeba","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105264_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cardfail.2020.07.010","article-title":"Metabolomic profile in HFpEF vs HFrEF patients","volume":"26","author":"Hage","year":"2020","journal-title":"J\u00a0Card Fail"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105264_bib8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2024.105264_bib9","article-title":"Regulations of myo-inositol homeostasis: mechanisms, implications, and perspectives","volume":"87","author":"Su","year":"2022","journal-title":"Adv Biomed Res"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105264_bib10","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/db19-0935","article-title":"Myo-inositol oxygenase (MIOX) overexpression drives the progression of renal tubulointerstitial injury in diabetes","volume":"69","author":"Sharma","year":"2020","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105264_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00234656","article-title":"Kinetics and specificity of the renal Na+\/myo-inositol cotransporter expressed in Xenopus oocytes","volume":"143","author":"Hager","year":"1995","journal-title":"J\u00a0Membr Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105264_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2012.04.010","article-title":"Contributions in astrocytes of SMIT1\/2 and HMIT to myo-inositol uptake at different concentrations and pH","volume":"61","author":"Fu","year":"2012","journal-title":"Neurochem Int"},{"issue":"38","key":"10.1016\/j.ebiom.2024.105264_bib13","doi-asserted-by":"crossref","first-page":"35219","DOI":"10.1074\/jbc.M204321200","article-title":"Identification of a novel Na+\/myo-inositol cotransporter","volume":"277","author":"Coady","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2024.105264_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep41166","article-title":"Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart","volume":"7","author":"Van Steenbergen","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105264_bib15","doi-asserted-by":"crossref","first-page":"H838","DOI":"10.1152\/ajpheart.00736.2019","article-title":"New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans","volume":"320","author":"Fert\u00e9","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ebiom.2024.105264_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12967-015-0661-3","article-title":"Metabolomic approach to profile functional and metabolic changes in heart failure","volume":"13","author":"Deidda","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105264_bib17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.ebiom.2024.105264_bib18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105264_bib19","article-title":"Meta-analysis global group in chronic (MAGGIC) heart failure risk score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction","volume":"7","author":"Rich","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12968-018-0477-4","article-title":"Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction","volume":"20","author":"Roy","year":"2018","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1532-429X-15-63","article-title":"Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method","volume":"14","author":"Kellman","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105264_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1541-0420.2006.00511.x","article-title":"Case-only analysis of treatment-covariate interactions in clinical trials","volume":"62","author":"Vittinghoff","year":"2006","journal-title":"Biometrics"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105264_bib23","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/ehf2.12816","article-title":"Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction","volume":"7","author":"Roy","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-001989","article-title":"Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes","volume":"9","author":"DiNicolantonio","year":"2022","journal-title":"Open Heart"},{"issue":"26","key":"10.1016\/j.ebiom.2024.105264_bib25","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jchromb.2011.07.043","article-title":"Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry","volume":"879","author":"Leung","year":"2011","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2024.105264_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cccn.2004.02.026","article-title":"A\u00a0study of urinary myo-inositol as a sensitive marker of glucose intolerance","volume":"344","author":"Sarashina","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2024.105264_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.689966","article-title":"Redefining COVID-19 severity and prognosis: the role of clinical and immunobiotypes","volume":"12","author":"Torres-Ruiz","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/clc.23754","article-title":"Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: a systemic review and meta-analysis","volume":"45","author":"Liang","year":"2022","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105264_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/00015385.2020.1770460","article-title":"Heart failure with preserved ejection fraction in Belgium: characteristics and outcome of a real-life cohort","volume":"76","author":"Lejeune","year":"2021","journal-title":"Acta Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105264_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007901","article-title":"Global differences in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"14","author":"Tromp","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105264_bib31","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/diagnostics11122291","article-title":"Estimating glomerular filtration rate from serum myo-inositol, valine, creatinine and cystatin C","volume":"11","author":"St\u00e4mmler","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17599-w","article-title":"Serum myo-inositol oxygenase levels at hospital discharge predict progression to chronic kidney disease in community-acquired acute kidney injury","volume":"12","author":"Kakkanattu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105264_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction","volume":"271","author":"Streng","year":"2018","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105264_bib34","first-page":"2333","article-title":"Investigating genetic determinants of plasma inositol status in adult humans","volume":"152","author":"Weston","year":"2022","journal-title":"J\u00a0Nutr"},{"issue":"7838","key":"10.1016\/j.ebiom.2024.105264_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"issue":"7924","key":"10.1016\/j.ebiom.2024.105264_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"issue":"6594","key":"10.1016\/j.ebiom.2024.105264_bib37","article-title":"The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"issue":"7817","key":"10.1016\/j.ebiom.2024.105264_bib38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-020-2496-1","article-title":"A\u00a0single-cell transcriptomic atlas characterizes ageing tissues in the mouse","volume":"583","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105264_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1096916","article-title":"Functional analysis of the coronary heart disease risk locus on chromosome 21q22","volume":"2017","author":"Beaney","year":"2017","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"Authors\/Task Force","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105264_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cjca.2019.08.033","article-title":"Direct effects of empagliflozin on extracellular matrix remodelling in human cardiac myofibroblasts: novel translational clues to explain EMPA-REG OUTCOME results","volume":"36","author":"Kang","year":"2020","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105264_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-021-01312-8","article-title":"Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGF\u03b21\/Smad signaling","volume":"20","author":"Zhang","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105264_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.112.191593","article-title":"Tofogliflozin, a potent and highly specific sodium\/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice","volume":"341","author":"Suzuki","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105264_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/ph15020203","article-title":"Associations of plasma concentration profiles of dapagliflozin, a selective inhibitor of sodium-glucose Co-transporter type 2, with its effects in Japanese patients with type 2 diabetes mellitus","volume":"15","author":"Hayakawa","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"27","key":"10.1016\/j.ebiom.2024.105264_bib45","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:28:27Z","timestamp":1727483307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"alternative-id":["S2352396424003001"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105264","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105264"}}